Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.3.5.1 (
succinate dehydrogenase
)
8,177
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Highly purified succinate-ubiquinone reductase catalyzes the oxidation of L- or D-malate with a Km and initial Vmax equal to approximately 10(-3) M and approximately 100 nmol/min/mg of protein, respectively. The malate dehydrogenase activity of
succinate dehydrogenase
rapidly decreases regardless of the presence of glutamate plus glutamate-oxaloacetate transaminase. The inhibitor trapping system, however, prevents the inactivation of
succinate dehydrogenase
under the conditions when the rate of tautomeric oxaloacetate enol in equilibrium oxaloacetate ketone interconversion is high. These results suggest that enol oxaloacetate is an immediate product of malate oxidation at the
succinate dehydrogenase
active site. Two proteins (Mr 37 and 80 kD) which catalyze the
oxaloacetate tautomerase
reaction were isolated from the mitochondrial matrix. Some physico-chemical and kinetic properties of these enzymes were characterized. The larger protein was identified as inactive aconitase. The system containing
succinate dehydrogenase
, L-malate, glutamate plus transaminase and
oxaloacetate tautomerase
was reconstituted. Such a system is capable of oxidizing malate to aspartate without rapid inactivation of
succinate dehydrogenase
. Taken together, the data obtained emphasize a significant role of enzymatic oxaloacetate tautomerization in the control of the
succinate dehydrogenase
activity in the mitochondrial matrix.
...
PMID:Regulation of succinate dehydrogenase and tautomerization of oxaloacetate. 262 74
The purified succinate-ubiquinone reductase catalyzes the L- (or D-) malate: acceptor oxidoreductase reaction with Km for malate of about 2.10(-3) M and initial Vmax of 50 and 100 nmol per min per mg of protein for L- and D-stereoisomers, respectively (25 degrees C, pH 7.0). The reaction rate rapidly decreases both in the absence and presence of L-glutamate and L-glutamate-oxaloacetate transaminase added for trapping of oxaloacetate. Both keto and enol forms of oxaloacetate were found to be strong, slowly dissociating inhibitors of
succinate dehydrogenase
; the first-order rate constant for the enzyme inhibition by the enol form is about 3 times as high as that by the keto form. Oxidation of malate by
succinate dehydrogenase
in the presence of the oxaloacetate trapping system occurs at an indefinitely constant rate when enoloxaloacetate, which is an immediate product of the reaction, is rapidly converted into the keto isomer--a substrate for transaminase. A quantitative kinetic scheme for malate oxidation by
succinate dehydrogenase
which includes two kinetically distinct enzyme-oxaloacetate complexes is proposed, and the specific role of the mitochondrial oxaloacetate keto-enol-tautomerase (
EC 5.3.2.2
) in the regulation of
succinate dehydrogenase
is suggested.
...
PMID:Oxidation of malate by the mitochondrial succinate-ubiquinone reductase. 290 78